medalphabetМедицинский алфавитMedical alphabet2078-56312949-2807ООО «Альфмед»10.33667/2078-5631-2024-16-65-68medalphabet-3844Research ArticleСтатьиВлияние физической нагрузки на мозговой натрийуретический пептид при различных состояниях сердечно-сосудистой системы: обзор предметного поляThe effect of physical activity on the brain natriuretic peptide in various conditions of the cardiovascular system: a review of the subject fieldhttps://orcid.org/0000-0002-4982-5615МештельА. В.MeshtelA. V.

Мештель Александр Виталиевич, аспирант кафедры спортивной медицины, ассистент кафедры анатомии и биологической антропологии

Москва

Meshtel Alexander V., postgraduate student of Dept of Sports Medicine, assistant at Dept of Anatomy and Biological Anthropology

Moscow

meshtel.author@yandex.ruhttps://orcid.org/0000-0002-4030-0302МирошниковА. Б.MiroshnikovA. B.

Мирошников Александр Борисович, д. б. н., доцент, декан факультета адаптивной физической культуры, рекреации и туризма, проф. кафедры спортивной медицины

Москва

Miroshnikov Alexander B., Dr Bio Sci, associate professor, dean of the Faculty of Adaptive Physical Culture, Recreation and Tourism, professor at Dept of Sports Medicine

Moscow

benedikt116@mail.ruhttps://orcid.org/0000-0001-5663-9936СмоленскийА. В.SmolenskyA. V.

Смоленский Андрей Вадимович, академик РАЕН, д. м. н., проф., зав. кафедрой спортивной медицины

Москва

Smolensky Andrey V., academician of the Russian Academy of Natural Sciences, DM Sci (habil.), professor, head of Dept of Sports Medicine

Moscow

chair.sportmed@gtsolifk.ruФГБОУ ВО «Российский университет спорта “ГЦОЛИФК”»РоссияRussian University of Sports “GTSOLIFK”Russian Federation202405092024016Диетология и нутрициология6568Copyright © Мештель А.В., Мирошников А.Б., Смоленский А.В., 20242024Мештель А.В., Мирошников А.Б., Смоленский А.В.Meshtel A.V., Miroshnikov A.B., Smolensky A.V.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.med-alphabet.com/jour/article/view/3844

В данном обзоре предметного поля рассматриваются мозговой натрийуретический пептид и его предшественник – N-концевой про- мозговой натрийуретический пептид – как маркер для оценки эффективности реабилитационных программ, включающих физические нагрузки, при таких заболеваниях, как артериальная гипертензия, хроническая сердечная недостаточность, ишемическая болезнь сердца и др. Кроме того, рассматривается реакция данного пептида на физическую нагрузку у здоровых людей.

In this review of the subject field, the brain natriuretic peptide and its predecessor, the N-terminal pro-brain natriuretic peptide, are considered as a marker for evaluating the effectiveness of rehabilitation programs, including physical activity, in diseases such as arterial hypertension, chronic heart failure, coronary heart disease and other diseases. In addition, the reaction of this peptide to physical activity in healthy people is considered.

мозговой натрийуретический пептидкардиореабилитацияишемическая болезнь сердцафизическая реабилитацияхроническая сердечная недостаточностьbrain natriuretic peptidecardiorehabilitationcoronary heart diseasephysical rehabilitationchronic heart failureReferencesSimão A. F., Précoma D. B., de Andrade J. P., Filho H. C., Saraiva J. F.K., Oliveira G. M.M. I diretriz brasileira de prevenção cardiovascular. Arq. Bras. Cardiol. 2014; 102: 420–431. DOI: 10.5935/abc.2013S 012Simão A. F., Précoma D. B., de Andrade J. P., Filho H. C., Saraiva J. F.K., Oliveira G. M.M. I diretriz brasileira de prevenção cardiovascular. Arq. Bras. Cardiol. 2014; 102: 420–431. DOI: 10.5935/abc.2013S 012Cao Z., Jia Y., Zhu B. BNP and NT-proBNP as Diagnostic Biomarkers for Cardiac Dysfunction in Both Clinical and Forensic Medicine. Int J. Mol. Sci. 2019 Apr 12; 20 (8): 1820. DOI: 10.3390/ijms20081820Cao Z., Jia Y., Zhu B. BNP and NT-proBNP as Diagnostic Biomarkers for Cardiac Dysfunction in Both Clinical and Forensic Medicine. Int J. Mol. Sci. 2019 Apr 12; 20 (8): 1820. DOI: 10.3390/ijms20081820Schmitt W., Rühs H., Burghaus R., Diedrich C., Duwal S., Eissing T., Garmann D., Meyer M., Ploeger B., Lippert J. NT-proBNP Qualifies as a Surrogate for Clinical End Points in Heart Failure. Clin. Pharmacol. Ther. 2021 Aug; 110 (2): 498–507. DOI: 10.1002/cpt.2222Schmitt W., Rühs H., Burghaus R., Diedrich C., Duwal S., Eissing T., Garmann D., Meyer M., Ploeger B., Lippert J. NT-proBNP Qualifies as a Surrogate for Clinical End Points in Heart Failure. Clin. Pharmacol. Ther. 2021 Aug; 110 (2): 498–507. DOI: 10.1002/cpt.2222Fan J., Ma J., Xia N., Sun L., Li B., Liu H. Clinical Value of Combined Detection of CK-MB, MYO, cTnI and Plasma NT-proBNP in Diagnosis of Acute Myocardial Infarction. Clin. Lab. 2017 Mar 1; 63 (3): 427–433. DOI: 10.7754/Clin.Lab.2016.160533Fan J., Ma J., Xia N., Sun L., Li B., Liu H. Clinical Value of Combined Detection of CK-MB, MYO, cTnI and Plasma NT-proBNP in Diagnosis of Acute Myocardial Infarction. Clin. Lab. 2017 Mar 1; 63 (3): 427–433. DOI: 10.7754/Clin.Lab.2016.160533PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation / Tricco A. C., Lillie E., Zarin W. [et al]. Ann Intern Med. 2018; 169 (7): 467–473. DOI: 10.7326/M18-0850PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation / Tricco A. C., Lillie E., Zarin W. [et al]. Ann Intern Med. 2018; 169 (7): 467–473. DOI: 10.7326/M18-0850Bordbar S., Bigi M. A., Aslani A., Rahimi E., Ahmadi N. Effect of endurance and strength exercise on release of brain natriuretic peptide. J. Cardiovasc Dis Res. 2012 Jan; 3 (1): 22–5. DOI: 10.4103/0975-3583.91599Bordbar S., Bigi M. A., Aslani A., Rahimi E., Ahmadi N. Effect of endurance and strength exercise on release of brain natriuretic peptide. J. Cardiovasc Dis Res. 2012 Jan; 3 (1): 22–5. DOI: 10.4103/0975-3583.91599Cirer-Sastre R., Legaz-Arrese A., Corbi F., George K., Nie J., Carranza-García L.E., Reverter-Masià J. Cardiac Biomarker Release After Exercise in Healthy Children and Adolescents: A Systematic Review and Meta-Analysis. Pediatr. Exerc. Sci. 2019 Feb 1; 31 (1): 28–36. DOI: 10.1123/pes.2018-0058Cirer-Sastre R., Legaz-Arrese A., Corbi F., George K., Nie J., Carranza-García L.E., Reverter-Masià J. Cardiac Biomarker Release After Exercise in Healthy Children and Adolescents: A Systematic Review and Meta-Analysis. Pediatr. Exerc. Sci. 2019 Feb 1; 31 (1): 28–36. DOI: 10.1123/pes.2018-0058Hamasaki H. The Effects of Exercise on Natriuretic Peptides in Individuals without Heart Failure. Sports (Basel). 2016 May 31; 4 (2): 32. DOI: 10.3390/sports4020032Hamasaki H. The Effects of Exercise on Natriuretic Peptides in Individuals without Heart Failure. Sports (Basel). 2016 May 31; 4 (2): 32. DOI: 10.3390/sports4020032Legaz-Arrese A., López-Laval I., George K., Puente-Lanzarote J.J., Mayolas-Pi C., Serrano-Ostáriz E., Revilla-Martí P., Moliner-Urdiales D., Reverter-Masià J. Impact of an endurance training program on exercise-induced cardiac biomarker release. Am. J. Physiol. Heart Circ Physiol. 2015 Apr 15; 308 (8): H913–20. DOI: 10.1152/ajpheart.00914.2014Legaz-Arrese A., López-Laval I., George K., Puente-Lanzarote J.J., Mayolas-Pi C., Serrano-Ostáriz E., Revilla-Martí P., Moliner-Urdiales D., Reverter-Masià J. Impact of an endurance training program on exercise-induced cardiac biomarker release. Am. J. Physiol. Heart Circ Physiol. 2015 Apr 15; 308 (8): H913–20. DOI: 10.1152/ajpheart.00914.2014Mandroukas A., Metaxas T. I., Heller J., Vamvakoudis E., Christoulas K., Riganas C. S., Sendelides T., Stefanidis P., Kotoglou K., Karamouzis I., Mandroukas K. The effect of different exercise-testing protocols on atrial natriuretic peptide. Clin Physiol Funct Imaging. 2011 Jan; 31 (1): 5–10. DOI: 10.1111/j.1475–097X.2010.00971.xMandroukas A., Metaxas T. I., Heller J., Vamvakoudis E., Christoulas K., Riganas C. S., Sendelides T., Stefanidis P., Kotoglou K., Karamouzis I., Mandroukas K. The effect of different exercise-testing protocols on atrial natriuretic peptide. Clin Physiol Funct Imaging. 2011 Jan; 31 (1): 5–10. DOI: 10.1111/j.1475–097X.2010.00971.xKoretskaya A. Y. Endurance and combined endurance-resistance training in patients with chronic heart failure and preserved ejection fraction. Kuban scientific medical bulletin. 2009; 4 (109): 98–103.Koretskaya A. Y. Endurance and combined endurance-resistance training in patients with chronic heart failure and preserved ejection fraction. Kuban scientific medical bulletin. 2009; 4 (109): 98–103.Nilsson B. B., Westheim A., Risberg M. A., Arnesen H., Seljeflot I. No effect of groupbased aerobic interval training on N-terminal pro- B-type natriuretic peptide levels in patients with chronic heart failure. Scand. Cardiovasc. J. 2010 Aug; 44 (4): 223–9. DOI: 10.3109/14017431.2010.496869Nilsson B. B., Westheim A., Risberg M. A., Arnesen H., Seljeflot I. No effect of groupbased aerobic interval training on N-terminal pro- B-type natriuretic peptide levels in patients with chronic heart failure. Scand. Cardiovasc. J. 2010 Aug; 44 (4): 223–9. DOI: 10.3109/14017431.2010.496869Passino C., Severino S., Poletti R., Piepoli M. F., Mammini C., Clerico A., Gabutti A., Nassi G., Emdin M. Aerobic training decreases B-type natriuretic peptide expression and adrenergic activation in patients with heart failure. J. Am. Coll. Cardiol. 2006 May 2; 47 (9): 1835–9. DOI: 10.1016/j.jacc.2005.12.050Passino C., Severino S., Poletti R., Piepoli M. F., Mammini C., Clerico A., Gabutti A., Nassi G., Emdin M. Aerobic training decreases B-type natriuretic peptide expression and adrenergic activation in patients with heart failure. J. Am. Coll. Cardiol. 2006 May 2; 47 (9): 1835–9. DOI: 10.1016/j.jacc.2005.12.050Lara Fernandes J., Serrano C. V., Toledo F., Hunziker M. F., Zamperini A., Teo F. H., Oliveira R. T., Blotta M. H., Rondon M. U., Negrão C. E. Acute and chronic effects of exercise on inflammatory markers and B-type natriuretic peptide in patients with coronary artery disease. Clin. Res Cardiol. 2011 Jan; 100 (1): 77–84. DOI: 10.1007/s00392-010-0215-xLara Fernandes J., Serrano C. V., Toledo F., Hunziker M. F., Zamperini A., Teo F. H., Oliveira R. T., Blotta M. H., Rondon M. U., Negrão C. E. Acute and chronic effects of exercise on inflammatory markers and B-type natriuretic peptide in patients with coronary artery disease. Clin. Res Cardiol. 2011 Jan; 100 (1): 77–84. DOI: 10.1007/s00392-010-0215-xBadiani S., van Zalen J., Althunayyan A., Al-Borikan S., Treibel T., Marshall A., Patel N., Bhattacharyya S., Lloyd G. Natriuretic peptide release during exercise in patients with valvular heart disease: A systematic review. Int J. Clin. Pract. 2021 Oct; 75 (10): e14137. DOI: 10.1111/ijcp.14137Badiani S., van Zalen J., Althunayyan A., Al-Borikan S., Treibel T., Marshall A., Patel N., Bhattacharyya S., Lloyd G. Natriuretic peptide release during exercise in patients with valvular heart disease: A systematic review. Int J. Clin. Pract. 2021 Oct; 75 (10): e14137. DOI: 10.1111/ijcp.14137Giallauria F., de Lorenzo A., Pilerci F., Manakos A., Lucci R., Psaroudaki M., D’Agostino M., Del Forno D., Vigorito C. Reduction of N terminal-pro-brain (B-type) natriuretic peptide levels with exercise-based cardiac rehabilitation in patients with left ventricular dysfunction after myocardial infarction. Eur. J. Cardiovasc Prev Rehabil. 2006 Aug; 13 (4): 625–32. DOI: 10.1097/01.hjr.0000209810.59831.f4Giallauria F., de Lorenzo A., Pilerci F., Manakos A., Lucci R., Psaroudaki M., D’Agostino M., Del Forno D., Vigorito C. Reduction of N terminal-pro-brain (B-type) natriuretic peptide levels with exercise-based cardiac rehabilitation in patients with left ventricular dysfunction after myocardial infarction. Eur. J. Cardiovasc Prev Rehabil. 2006 Aug; 13 (4): 625–32. DOI: 10.1097/01.hjr.0000209810.59831.f4Kutsch J., Faul C., von Scheidt W., Schwaiblmair M., Berghaus T. M. The association of the N-terminal pro-brain-type natriuretic peptide response to exercise with disease severity in therapy-naive pulmonary arterial hypertension: a cohort study. Respir Res. 2018 Jan 15; 19 (1): 8. DOI: 10.1186/s12931-017-0712-9Kutsch J., Faul C., von Scheidt W., Schwaiblmair M., Berghaus T. M. The association of the N-terminal pro-brain-type natriuretic peptide response to exercise with disease severity in therapy-naive pulmonary arterial hypertension: a cohort study. Respir Res. 2018 Jan 15; 19 (1): 8. DOI: 10.1186/s12931-017-0712-9

The authors declare that there are no conflicts of interest present.